WisdomTree (NasdaqGS: WETF), the fifth-largest U.S. sponsor of exchange traded funds, earlier this week announced the expansion of its Latin America footprint, saying it received approval to list 12 of its ETFs in Peru.
New York-based WisdomTree said the the Superintendencia de Banca, Seguros y AFP (SBS), the Peruvian pension funds investment regulator, approved a dozen of the issuer’s ETFs for sale to Peruvian pension funds, according to a statement.
ETF adoption continues to increase throughout Latin America. We are pleased that 12 of our ETFs are approved for sale to Peruvian pension funds, further expanding our global footprint,” said Luciano Siracusano, WisdomTree Chief Investment Strategist, in the statement.
Among the ETFs WisdomTree will be able to market to Peruvian pension plans are the $4 billion WisdomTree Emerging Markets Equity Income Fund (NYSEArca: DEM), the $1.7 billion WisdomTree LargeCap Dividend Fund (NYSEArca: DLN) and the $950.6 million WisdomTree Europe Hedged Equity Fund (NYSEArca: HEDJ).
Peruvian pension funds currently hold $40 billion in assets, according to WisdomTree.
WisdomTree’s Peruvian plans are not the company’s first foray into South America. In November 2013, WisdomTree said the Comision Clasificadora de Riesgo (CCR), the Chilean pension funds investment regulator, approved three additional WisdomTree ETFs for sale to Chilean pension funds, bringing the number of WisdomTree ETFs available to Chilean pensioners to 13. [Latin America: A New Frontier for ETF Growth]
Other ETF issuers with eyes on Chile as well as other LatAm nations include BlackRock’s (NYSE: BLK) iShares, State Street’s (NYSE: STT) State Street Global Advisors and Vanguard, the three largest U.S. ETF issuers.
WisdomTree ETFs Approved by the Superintendencia de Banca, Seguros y AFP
Table Courtesy: WisdomTree
ETF Trends editorial team contributed to this post. Tom Lydon’s clients own shares of DEM and HEDJ.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.